French microbiologist Emmanuelle Charpentier, who was named a co-winner of the second Tang Prize in biopharmaceutical science on Sunday for her work in the development of CRISPR/Cas9, said she hopes the genome editing technology can be used to treat currently incurable conditions.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Labor ministry updates rules expanding shutdowns after work accidents
07/08/2025 11:01 PM - Business
Taiwan's consumer price index eases to 1.37%, a 4-year low: DGBAS
07/08/2025 10:36 PM - Society
2 dead after dinghy capsizes in New Taipei rescue mission
07/08/2025 10:12 PM - Business
Taiwan's exports rise for 20th straight month to new high in June
07/08/2025 09:53 PM - Cross-Strait
CAA addresses Chinese civilian plane flying over Kinmen
07/08/2025 09:27 PM